Background: Increasing epithelial chloride (Cl Ϫ ) secretion in the upper airways represents a putative method for promoting mucociliary clearance through augmentation of airway surface liquid depth. Several naturally occurring flavonoid compounds, including quercetin, have shown the capacity to increase transepithelial Cl Ϫ transport. Quercetin exhibits well-known antioxidant and anti-inflammatory activity and is now recognized as a potent activator of the cystic fibrosis transmembrane conductance regulator (CFTR) anion channel activity in a fashion largely independent of cyclic adenosine monophosphate signaling. The present study investigates whether this compound activates Cl Ϫ secretion and ciliary beat frequency (CBF) in well-characterized culture models of sinonasal epithelium.
S inonasal mucosal inflammation and decreased mucociliary clearance (MCC) are major contributing factors to the pathophysiology of chronic rhinosinusitis. MCC is primarily determined by the sinonasal respiratory epithelium, a highly regulated barrier. Respiratory epithelium modifies the volume of the periciliary fluid layer 1 and the viscoelastic properties of the mucus through vectorial ion transport. 2 Decreased epithelial chloride (Cl Ϫ ) transport decreases MCC through dehydration of airway surface liquid (ASL) and is clearly shown in the lethal inherited disease, cystic fibrosis. Pharmacologic agents designed specifically to enhance ASL hydration and MCC represent a novel approach to treating chronic rhinosinusitis but have not been characterized in models representative of the sinus and nasal airway. One promising therapeutic group of naturally occurring com-pounds that may have salutary effects on sinus infections are flavonoids, although the activity of these agents in the upper airways is not well understood.
Flavonoids are comprised of a wide array of ubiquitous plant compounds that have the basic structural feature of a 2-phenylbenzo(y)pyrone nucleus. The class of agents exhibits a number of biological effects critical to human health and has been shown previously to confer antibacterial, antiviral, anti-inflammatory, and antiallergic effects. 3, 4 Owing to its well-established safety profile in humans and its anti-inflammatory effects, the flavonoid quercetin has been tested in a variety of clinical trials. [5] [6] [7] Recently, our group has characterized the Cl Ϫ secretory properties of quercetin in cultured cell lines and in vivo airways. 8 Although this finding has important implications for promoting Cl Ϫ secretion and hydration of ASL, the properties of quercetin still have to be fully investigated in primary cultured sinonasal epithelia, and the downstream effects on cilia beating have not been tested. Furthermore, little is known about the effects of flavonoid compounds on ciliary beating. This study aimed to measure the effects of quercetin in augmenting transepithelial Cl Ϫ transport and ciliary beat frequency (CBF) in primary sinonasal epithelial cell cultures.
METHODS
Institutional animal care and use committee and institutional review board approval were obtained before the initiation of the study.
Cell Culture
Primary murine nasal septal epithelial (MNSE) and human sinonasal epithelial (HSNE) cultures were used in the current study. MNSE filters were derived from genetically matched (congenic) C57 wildtype (w.t.) mice. Transgenic cystic fibrosis transmembrane conductance regulator (CFTR Ϫ/Ϫ ) (knockout) MNSE cultures were also in-
vestigated to test a CFTR-dependent mechanism. Culturing of epithelia at an air-liquid interface is well described in our prior studies. [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] Briefly, MNSE cells were harvested and grown on Costar 6.5-mm-diameter permeable filter supports (Corning Life Sciences, Lowell, MA) submerged in culture medium. The apical surfaces of the epithelial monolayers were exposed to air on day 4 after reaching confluence and cells were fed via the basal chamber. Under these conditions, differentiation and ciliogenesis occurs within 10-14 days, generating cultures with Ͼ90% cilia in each monolayer.
Insert Summary
A total of 205 MNSE and 42 HSNE cell cultures were used in the completion of these studies. Cultures with transepithelial resistances (R t ) of Ͼ500 ⍀ ‫ء‬ cm 2 were used to obtain Ussing chamber measurements and monitor ciliary beating with an inverted microscope. A minimum of 6 wells were used per condition.
Solutions and Chemicals
The bath solution contained 120 mM of NaCl, 25 mM of NaHCO 3 Amiloride was used to block epithelial sodium channel activity, ensuring that the change in short-circuit current (⌬I SC ) from subsequent manipulation is secondary to effects on Cl Ϫ transport. Forskolin activates CFTR via a cyclic adenosine monophosphate (cAMP)-mediated mechanism. H89 is a protein kinase A inhibitor that prevents cAMP-dependent pathway phosphorylation (activation) of the regulatory domain (RD) in CFTR. CFTR inh -172 is a specific inhibitor of CFTR 12 and is designed to allow comparisons of the relative contribution of CFTR to the I SC in different systems.
CBF Analysis
Images were visualized using a 20ϫ objective on an inverted scope (Fisher Scientific, Pittsburgh, Pa.). Data are captured using a Model A602f-2 Basler area scan high-speed monochromatic digital video camera (Basler AG, Ahrensburg, Germany) at a sampling rate of 100 frames/s and a resolution of 640 ϫ 480 pixels. Images were analyzed using the Sisson-Ammons Video Analysis system Version 2.1.6 (Ammons Engineering, Mt. Morris, MI). For each experiment, a large area of beating cilia on air-liquid interface cultures was identified with the inverted microscope. The digital image signal was then routed from the camera directly into an acquisition board (National Instruments) within a Dell Workstation (Dell, Austin, TX) running the Windows XP Professional operating system (Microsoft Redmond, WA). Images were analyzed with virtual instrumentation software for CBF analysis. All recordings were made at 200ϫ magnification.
Experiments were all performed at ambient temperature (23°C). A baseline recording of CBF was conducted for each cell monolayer before apical administration of test solution, because apical fluid addition, by itself, can increase CBF. Additional fluid depth overlying the respiratory epithelial cell surface stimulates CBF because of improved hydration and optimal fluid dynamics. Thus, all experiments compared the effects of agonists to that of a PBS control solution. In some studies, quercetin was mixed with the basal culture media. Whole field analysis was performed with each point measured representing one cilia. The reported frequencies describe arithmetic means of these values, followed by SDs. Each analysis was normalized to fold change over baseline.
Statistics
For I sc and CBF (fold change), descriptive statistics (mean, SD, and SEM) were compared using Student's t-test or ANOVA, as appropri-ate. All statistical tests were two sided and were performed at a 5% significance level (i.e., ␣ ϭ 0.05) using Microsoft Excel (Seattle, WA).
RESULTS

Transepithelial Cl ؊ Transport
Changes in ⌬I SC (measured in A/cm 2 ) were significantly higher when MNSE cultures were exposed to 10 M of quercetin (4.94 Ϯ 1.93) than when exposed to DMSO control (1.45 Ϯ 1.52; p Ͻ 0.0001). Maximal effects were shown with 50 M of quercetin (26.26 Ϯ 8.03) when compared with the control vehicle (DMSO; 2.02 Ϯ 1.18; p Ͻ 0.0001) ( Fig. 1 A) . In addition, 50 M of quercetin markedly increased ⌬I SC after the administration of 100 nM of forskolin (23.23 Ϯ 5.44) compared with 100 nM of forskolin followed by control solution (2.47 Ϯ 1.62; p Ͻ 0.0001) showing potentiation of cAMP-dependent CFTR activity. However, at higher doses (200 M) of quercetin, there was an initial peak, followed by inhibition of Cl Ϫ secretion. Regardless of the order in which forskolin and quercetin were administered, total CFTR stimulation was significantly higher in the quercetin (dose)-treated group (48.51 Ϯ 9.32) than in DMSO controls (26.79 Ϯ 7.65; p Ͻ 0.0001) ( Fig. 1 B) . Quercetin's effects were specific to apical application of the agent (Fig. 1 C) . Blockade of anion transport by the CFTR chloride channel inhibitor CFTR inh -172 showed a significant difference between groups (quercetin, Ϫ27.07 Ϯ 8.89 versus DMSO control; 15.71 Ϯ 8.35; p Ͻ 0.01), indicating that the effects of quercetin are CFTR dependent. Blockade of PKA with H89 (20 M) eliminated the effects of quercetin, indicating that at least some baseline PKA activity (activation/phosphorylation of the RD in CFTR) is necessary for quercetin's potentiating action ( Fig. 1 D) . Quercetin also significantly increased CFTR-mediated I SC in HSNE cultures (Ϫ8.72 Ϯ 1.88 versus Ϫ1.88 Ϯ 0.66; p Ͻ 0.01), indicating that the effects of quercetin are applicable to both murine and human CFTR (Fig. 2) . The ion transport phenotype of HSNE cultures is of smaller magnitude when compared with MNSE. 12
Ciliary Beat Frequency
Robust stimulation of CBF was observed with concentrations of quercetin up to 10 M, but no further elevation was encountered despite increasing doses up to 200 M. Thus, 10 M was used as the working concentration for CBF analysis. CBF (expressed as fold change over baseline) significantly increased after quercetin addition to the apical surface in comparison with control (PBS) solution (1.65 Ϯ 0.13 versus 1.23 Ϯ 0.05, respectively; p Ͻ 0.01), although efficacy was less than that observed with known CBF stimulants UTP (150 M) and forskolin (100 nM; 2.1 Ϯ 0.38 and 2.41 Ϯ 0.37, respectively; Fig. 3 ). The effects of quercetin on CBF were specific to apical addition. Quercetin delivered to the basal media did not significantly increase Fig. 4 ).
To isolate the effects of quercetin on anion transport, we next tested CBF in the presence of amiloride to inhibit ENaC. In the presence of amiloride (100 M), quercetin stimulation of CBF was observed (1.85 Ϯ 0.18 versus 1.44 Ϯ 0.17 [control] ; p Ͻ 0.01) and was similar to the effect on cultures tested without sodium channel blockade (Fig. 4) 21 we initially attributed the relative increase in CBF with PBS application in CFTR Ϫ/Ϫ cells (in comparison with w.t.) to restoration of the apical fluid volume. Subsequent tests supporting this hypothesis included amiloride in CFTR Ϫ/Ϫ cells to block excess Na transport in CFTR Ϫ/Ϫ cultures. Results of these experiments showed no significant increase in CBF with the administration of quercetin (1.93 Ϯ 0.11) over PBS control (1.75 Ϯ 0.11), indicating the effects of quercetin on CBF are primarily caused by augmenting Cl Ϫ transport (as opposed to altering Na ϩ conductance).
Primary HSNE cultures derived from individuals with functional CFTR had a modest, but significant increase in CBF after application of quercetin (10 M) when compared with DMSO control (1.37 Ϯ 0.13 versus 1.24 Ϯ 0.11, respectively; p Ͻ 0.05). Analogous to explants in CFTR Ϫ/Ϫ mice, quercetin did not augment CBF in homozygous F508del HSNE (1.13 Ϯ 0.1 versus 1.11 Ϯ 0.08 [control]; Fig. 5 ).
DISCUSSION
CFTR is a Cl Ϫ channel in the apical membrane of respiratory epithelia and is crucial for modulating ASL via salt and water secretion and absorption. CFTR dysfunction results in severe respiratory disease in cystic fibrosis, but may also be dysfunctional in other conditions, such as cigarette smoke exposure. 13 Drug discovery efforts have centered on small molecules that target CFTR 22, 23 to treat respiratory diseases. Flavonoids are one such group of molecules shown to affect CFTR activity and CFTR-mediated currents. 22, 24, 25 In the current study, we evaluated the propensity for quercetin to activate CFTR-dependent Cl Ϫ transport in primary cell culture models of sinonasal epithelium. The findings of this study indicate quercetin robustly activates CFTR in upper airway cell monolayers. Similar to other studies, quercetin causes a dose-dependent increase in . Relative stimulation of CBF was slightly enhanced in the presence of amiloride (1.85 Ϯ 0.18 versus 1.44 Ϯ 0.17; p Ͻ 0.01), although not significantly different when compared with cultures without sodium channel blockade. Cells blocked with the CFTR inhibitor CFTR inh -172 completely suppressed quercetin-stimulated CBF. In addition, quercetin did not activate CBF in cultures derived from CFTR knockout mice over that observed with PBS alone (p ϭ 0.23). Incubation with amiloride increased CBF when exposed to both PBS (1.75 Ϯ 0.08) and quercetin (1.93 Ϯ 0.11). All CBF rates were obtained at 15 minutes. Interestingly, significant inhibition was seen at higher doses ( Fig. 3) as also reported previously in lower airway cultures. 8, 24, 26 This biphasic response has been observed in other flavonoids, including quercetin. For example, in colon epithelial cell lines, quercetin activated Cl Ϫ currents at concentrations of 5 mol/L but had significant inhibition at higher doses. 27 Our studies indicate that quercetin's effects are CFTR dependent, based on inhibition of the response to CFTR inh -172 and dependence on CFTR expressing epithelium. In addition, the effects of quercetin were similar whether the agent was added before or after forskolin, showing that preactivation with an adenylate cyclase activator is not necessary for the observed effects. However, the PKA inhibitor H89 eliminated quercetin's Cl Ϫ secretory properties, indicating some baseline activation of CFTR (via phosphorylation of the RD) is required to augment Cl Ϫ transport. This is consistent with prior studies by our group indicating that the mechanistic effects of quercetin may differ from classic PKA-dependent stimuli, such as forskolin (i.e., phosphorylation of the RD). 8 Additional experiments will be required to determine the precise mechanism of action underlying robust stimulation of Cl Ϫ secretion conferred by this agent.
Quercetin also robustly activated CBF when applied to the respiratory epithelial cell surface-a finding not previously reported with this agent. Our studies were performed by submerging the entire epithelial cell surface with either quercetin or control solutions, which should minimize the influence of augmented ASL depth alone as a mechanism underlying activation of CBF. However, it is plausible that the effects observed were compartmentalized changes in the ASL periciliary layer (sol), because increased CBF was observed after ENaC blockade. 28 Similarly, quercetin addition could confer small compartmentalized changes in the periciliary fluid layer not altered by the addition of exogenous apical surface fluid. Results indicating effects on CBF are dependent on CFTR with both pharmacologic blockade (CFTR inh -172) and transgenic CFTR Ϫ/Ϫ cultures providing additional support for this theory.
Flavonoids are ubiquitous compounds present in human foods, have excellent bioavailability, and have an excellent safety profile when administered through oral or i.v. means. 5, 6, 29 The flavonoid quercetin has undergone extensive preclinical and clinical testing for various human conditions. In a study examining quercetin as a tyrosine kinase inhibitor, i.v. doses exceeding 1700 mg/m 2 induced transient elevations in serum creatinine, but doses below this thresh-old were well tolerated for 6-7 months. 5 In a hypertension trial, oral quercetin (730 mg daily) for 28 days produced no significant adverse events. 30 Prior studies indicate quercetin also has the ability to enhance Cl Ϫ transport through CFTR and, thus, has been investigated as an agent for differentiating between w.t. and mutant CFTR in cystic fibrosis. 32 Quercetin has previously been shown to efficiently activate CFTR in single cells, polarized cell lines, and stimulate CFTR when administered topically to the nasal mucosa as part of the in vivo nasal potential difference testing and was well tolerated with nasal perfusion. 24 Our model of quercetin stimulation of CFTR and CBF (Fig. 6) is consistent with prior studies from our center showing CFTR activation through interaction with the nucleotide binding domains rather than activation (phosphorylation) of the RD. 8 Based on studies presented here, stimulation of CBF appears to be dependent on CFTmediated anion transport and likely stimulates CBF through localized changes in the composition of the periciliary fluid, although other mechanisms such as altered viscosity of the mucus gel or direct activation of cilia beating may also contribute.
Although quercetin did not stimulate CBF or CFTR when cultures were exposed via the basal membrane, the effects with apical addition remained robust. These findings have relevance to the optimal route of quercetin administration (topical versus systemic) for use in nasal airways as a means to activate CFTR or augment cilia beating to improve MCC in diseased sinus airways.
CONCLUSION
In summary, the present study indicates quercetin is a robust CFTR-dependent Cl Ϫ secretagogue in murine and human nasal airway cells in vitro and provides new evidence that the compound is an activator of CBF. Our results (and the well-established safety profile in other human studies) offer a rationale for further studies using the agent in human protocols targeting topical administration to the sinuses, including individuals with relative deficiency in CFTR activity independent of congenital mutations in the CFTR gene. Figure 6 . Pharmacologic manipulation of ion transport and ciliary activation pathways with quercetin's suspected mechanism of action. Ciliary beat frequency (CBF) and cystic fibrosis transmembrane conductance regulator (CFTR) are activated through the PKA-dependent pathway. Cl Ϫ is transported via the basal membrane through basolateral potassium channels (NKCC-1) and secreted through CFTR at the apical surface. TMEM16A is a recently identified calcium-activated Cl Ϫ channel that also contributes to apical anion transport. 31 Activators (forskolin and quercetin) are indicated by the blue arrows and inhibitors by the red arrows (amiloride, CFTR inh -172, H89). The epithelial sodium channel (ENaC) is the primary apical Na ϩ channel. Quercetin is thought to act as a CFTR channel activator through its interactions with the nucleotide binding domains (NBD) rather than activation (phosphorylation) of the regulatory domain (RD). 8 
